CellaVision AB (STU:C26)
€ 21.8 1.3 (6.34%) Market Cap: 502.11 Mil Enterprise Value: 493.25 Mil PE Ratio: 36.72 PB Ratio: 7.18 GF Score: 100/100

Q1 2020 CellaVision AB Earnings Call Transcript

Apr 22, 2020 / 09:00AM GMT
Release Date Price: €24.2 (-6.78%)
Operator

Ladies and gentlemen, welcome to the CellaVision AB Q1 Report for 2020. Today, I am pleased to present CEO, Zlatko Rihter. (Operator Instructions)

I'll now hand the floor to Zlatko. Please begin your meeting.

Zlatko Rihter;publ;President;CEO
CellaVision AB

()-&

So good morning or -- and good day, everybody. My name is Zlatko Rihter, CEO of CellaVision. And with me today also have Magnus Blixt, the CFO of CellaVision; and Maria Morin, that is also heading HR and corporate communications. So we are free here around the telephone here in sunny Lund.

So basically, what I'll do, as usual, is go through the quarter reports, and I hope that you can all see the slide presentation. So please move to Slide #3. And I'll just give you a little bit of a highlights on the CellaVision business, and then we'll move into financials later on.

As you as you all understand, since before, I mean, the vision that CellaVision have is to become a global leader within digitalization and automated blood

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot